Studies have shown that activating the JAK-STAT3 pathway enhances migration (Okitsu et al., 2010), drug resistance, proliferation (Zhang et al., 2017), and stemness (Alcalá et al., 2019) of pancreatic cancer cells. The gene discussed is STAT3; the disease is pancreatic neoplasm.